Literature DB >> 12296860

Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12.

H F Löhr1, S Pingel, W O Böcher, H Bernhard, S Herzog-Hauff, S Rose-John, P R Galle.   

Abstract

Insufficient stimulatory capacities of autologous dendritic cells (DC) may contribute in part to impaired T cell stimulation and therefore viral persistence in patients with chronic hepatitis B virus (HBV) infection. In order to characterize the antigen presenting functions of DC from chronic HBV carriers and controls antigen specific T cell responses were analysed. CD34+ peripheral blood progenitor cells were differentiated to immature DC in the presence of GM-CSF, IL-6/IL-6R fusion protein and stem cell factor. Proliferative CD4+ T cell responses and specific cytokine release were analysed in co-cultures of DC pulsed with HBV surface and core antigens or tetanus toxoid and autologous CD4+ T cells. Cultured under identical conditions DC from chronic HBV carriers, individuals with acute resolved hepatitis B and healthy controls expressed similar phenotypical markers but chronic HBV carriers showed less frequent and weaker HBV antigen specific proliferative T helper cell responses and secreted less interferon-gamma while responses to the tetanus toxoid control antigen was not affected. Preincubation with recombinant IL-12 enhanced the HBV specific immune reactivities in chronic HBV patients and controls. In conclusion, the weak antiviral immune responses observed in chronic hepatitis B may result in part from insufficient T cell stimulating capacities of DC. Immunostimulation by IL-12 restored the HBV antigen specific T cell responses and could have some therapeutical benefit to overcome viral persistence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12296860      PMCID: PMC1906498          DOI: 10.1046/j.1365-2249.2002.01943.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.

Authors:  W O Böcher; S Herzog-Hauff; J Schlaak; K H Meyer zum Büschenfeld; H F Löhr
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

2.  Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.

Authors:  H F Löhr; S Krug; W Herr; S Weyer; J Schlaak; T Wölfel; G Gerken; K H Meyer zum Büschenfelde
Journal:  Liver       Date:  1998-12

3.  Comparative analysis of dendritic cells derived from blood monocytes or CD34+ hematopoietic progenitor cells.

Authors:  G Meierhoff; S W Krause; R Andreesen
Journal:  Immunobiology       Date:  1998-03       Impact factor: 3.144

Review 4.  Epidermal Langerhans cell development and differentiation.

Authors:  H Strobl; E Riedl; C Bello-Fernandez; W Knapp
Journal:  Immunobiology       Date:  1998-03       Impact factor: 3.144

5.  Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype.

Authors:  C M Hilkens; P Kalinski; M de Boer; M L Kapsenberg
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

6.  Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

Authors:  K Steinbrink; H Jonuleit; G Müller; G Schuler; J Knop; A H Enk
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

7.  A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B.

Authors:  H M Diepolder; M C Jung; E Keller; W Schraut; J T Gerlach; N Grüner; R Zachoval; R M Hoffmann; C A Schirren; S Scholz; G R Pape
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

8.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

Authors:  C Boni; A Bertoletti; A Penna; A Cavalli; M Pilli; S Urbani; P Scognamiglio; R Boehme; R Panebianco; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

Authors:  L G Guidotti; K Ando; M V Hobbs; T Ishikawa; L Runkel; R D Schreiber; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.

Authors:  E von Stebut; Y Belkaid; T Jakob; D L Sacks; M C Udey
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  9 in total

Review 1.  Host-virus interactions in hepatitis B and hepatitis C infection.

Authors:  Sachiyo Yoshio; Tatsuya Kanto
Journal:  J Gastroenterol       Date:  2016-02-19       Impact factor: 7.527

Review 2.  Current and future antiviral drug therapies of hepatitis B chronic infection.

Authors:  Lemonica Koumbi
Journal:  World J Hepatol       Date:  2015-05-18

3.  Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.

Authors:  Quan-Chu Wang; Zhi-Hua Feng; Yong-Xing Zhou; Qing-He Nie
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

4.  Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.

Authors:  Susanne Beckebaum; Vito R Cicinnati; Xia Zhang; Stanislav Ferencik; Andrea Frilling; Hans Grosse-Wilde; Christoph Erich Broelsch; Guido Gerken
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

5.  Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 alpha DCs induced in vivo by IFN-alpha in patients with chronic hepatitis B.

Authors:  Yong-Sheng Yu; Zheng-Hao Tang; Jing-Chao Han; Min Xi; Jie Feng; Guo-Qing Zang
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

6.  Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.

Authors:  Julien Crettaz; Itziar Otano; Laura Ochoa-Callejero; Laura Ochoa; Alberto Benito; Astrid Paneda; Igor Aurrekoetxea; Pedro Berraondo; Juan Roberto Rodríguez-Madoz; Aurora Astudillo; Florian Kreppel; Stefan Kochanek; Juan Ruiz; Stephan Menne; Jesus Prieto; Gloria Gonzalez-Aseguinolaza
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

7.  Treatment of chronic hepatitis B: are we ready for combination therapy?

Authors:  Anil Seetharam; Mauricio Lisker-Melman
Journal:  Curr Gastroenterol Rep       Date:  2009-02

8.  HBV-Specific Adaptive Immunity.

Authors:  Antonio Bertoletti; Anthony T Tan; Adam J Gehring
Journal:  Viruses       Date:  2009-07-27       Impact factor: 5.818

9.  Osteopontin promotes dendritic cell maturation and function in response to HBV antigens.

Authors:  Guangying Cui; Jianing Chen; Jianqin He; Chong Lu; Yingfeng Wei; Lin Wang; Xuejun Xu; Lanjuan Li; Toshimitsu Uede; Hongyan Diao
Journal:  Drug Des Devel Ther       Date:  2015-06-12       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.